x

Regulus Therapeutics Inc. (Nasdaq:RGLS)

Health Care/Life Sciences • Biotechnology
CIK 1505512
Company

Regulus Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the discovery and development of drugs targeting microRNAs. Its two lead product candidates, RG-012 and RGLS4326, are in clinical development. RG-012 is an anti-miR targeting miR-21 in Phase II clinical trial for the treatment of Alport syndrome, a life-threatening kidney disease. RGLS4326 is an anti-miR targeting miR-17 in Phase I clinical trial for the treatment of autosomal dominant polycystic kidney disease. The firm is also developing a pipeline of preclinical drug product candidates in renal, hepatic, and central nervous systems diseases. The company was founded on September 5, 2007 and is headquartered in San Diego, CA.

Address
4224 Campus Point Court
Suite 210
San Diego, California 92121
Employees
30
Stock Info
Close
$1.4900
Day Range
1.4500 - 1.5400
52 Week Range
0.7600 - 2.1400
Average volume
36.23K
Short Interest
97K (02/15/24)
% of Float Shorted
0.56%
Market Cap
$30.13M
Revenue
N/A
Net Income
-$28.32M
2020 Sales Growth
N/A
Rev. per Employee
N/A
P/E Ratio
N/A
EPS
-$1.5931
Yield
N/A
Dividend
N/A
Ex-Dividend Date
N/A
Key Executives
Board Of Directors
Chief Executive Officer & Director
Joseph P Hagan MBA
President, Director & Head-Research & Development
Preston S Klassen MD
Chairman
Stelios Papadopoulos PhD, MBA
Independent Director
Kathryn J Collier
Independent Director
Alice S Huang PhD
Independent Director
Pascale Witz MBA
Independent Director
Jake R Nunn CFA, MBA
Independent Director
Hugh Rosen MD, PhD
Independent Director
David Baltimore PhD
Independent Director
William H Rastetter PhD
SEC filings
DateFormEvent
14 Nov, 2024 SC 13G/A
14 Nov, 2024 SC 13G/A
14 Nov, 2024 SC 13G/A
12 Nov, 2024 SC 13G/A
8 Nov, 2024 SC 13G
7 Nov, 2024 8-K
7 Nov, 2024 10-Q
4 Nov, 2024 SC 13G/A
24 Oct, 2024 8-K
24 Oct, 2024 SC 13G
11 Oct, 2024 SC 13G
8 Aug, 2024 8-K
8 Aug, 2024 10-Q
29 Jul, 2024 4
24 Jun, 2024 8-K
21 May, 2024 4
21 May, 2024 4
21 May, 2024 4
21 May, 2024 4
21 May, 2024 4
21 May, 2024 4
21 May, 2024 4
21 May, 2024 4
21 May, 2024 4
21 May, 2024 4
21 May, 2024 4
21 May, 2024 4
20 May, 2024 S-8
17 May, 2024 4
17 May, 2024 4
17 May, 2024 4
17 May, 2024 4
17 May, 2024 4
17 May, 2024 4
17 May, 2024 4
17 May, 2024 4
17 May, 2024 8-K
9 May, 2024 424B5
9 May, 2024 10-Q
9 May, 2024 8-K
30 Apr, 2024 DEFA14A
19 Apr, 2024 DEF 14A
19 Apr, 2024 EFFECT
19 Apr, 2024 ARS
17 Apr, 2024 CORRESP
16 Apr, 2024 UPLOAD
10 Apr, 2024 SC 13G/A
9 Apr, 2024 S-3
25 Mar, 2024 SC 13G
22 Mar, 2024 SC 13G
21 Mar, 2024 8-K
21 Mar, 2024 10-K
20 Mar, 2024 SC 13G
18 Mar, 2024 SC 13D/A
15 Mar, 2024 4
14 Mar, 2024 8-K
14 Feb, 2024 SC 13G
9 Feb, 2024 SC 13G/A
6 Feb, 2024 SC 13G/A
18 Jan, 2024 4
18 Jan, 2024 4
18 Jan, 2024 4
18 Jan, 2024 SC 13G/A
17 Jan, 2024 4
17 Jan, 2024 4
17 Jan, 2024 4
17 Jan, 2024 4
12 Jan, 2024 S-8
9 Jan, 2024 EFFECT
5 Jan, 2024 CORRESP
2 Jan, 2024 UPLOAD
27 Dec, 2023 S-3
9 Nov, 2023 10-Q
9 Nov, 2023 8-K
14 Aug, 2023 4
14 Aug, 2023 4
14 Aug, 2023 4
14 Aug, 2023 4
14 Aug, 2023 4
14 Aug, 2023 4
14 Aug, 2023 4
14 Aug, 2023 4
14 Aug, 2023 4
14 Aug, 2023 4
14 Aug, 2023 4
14 Aug, 2023 4
8 Aug, 2023 10-Q
8 Aug, 2023 8-K
29 Jun, 2023 S-8
23 Jun, 2023 8-K
14 Jun, 2023 8-K
13 Jun, 2023 4
13 Jun, 2023 4
13 Jun, 2023 4
13 Jun, 2023 4
13 Jun, 2023 4
13 Jun, 2023 4
13 Jun, 2023 4
13 Jun, 2023 4
12 Jun, 2023 3
12 Jun, 2023 4
12 Jun, 2023 8-K CEO Change
5 Jun, 2023 DEFA14A
22 May, 2023 CT ORDER
19 May, 2023 EFFECT
12 May, 2023 SC 13D/A
11 May, 2023 8-K
11 May, 2023 S-3
11 May, 2023 10-Q
10 May, 2023 SC 13G/A
28 Apr, 2023 DEFA14A
28 Apr, 2023 DEF 14A
28 Apr, 2023 ARS
14 Apr, 2023 4
13 Apr, 2023 8-K
23 Mar, 2023 8-K
23 Mar, 2023 10-K
1 Feb, 2023 SC 13G/A
31 Jan, 2023 SC 13G/A
17 Jan, 2023 4/A
17 Jan, 2023 4
17 Jan, 2023 4
17 Jan, 2023 4
11 Jan, 2023 S-8
6 Jan, 2023 8-K
12 Dec, 2022 8-K
14 Nov, 2022 10-Q
10 Nov, 2022 8-K
11 Oct, 2022 SC 13G
11 Aug, 2022 424B5
11 Aug, 2022 S-8
11 Aug, 2022 10-Q
11 Aug, 2022 8-K
15 Jul, 2022 8-K
27 Jun, 2022 8-K
13 Jun, 2022 8-K
10 Jun, 2022 4
10 Jun, 2022 4
10 Jun, 2022 4
10 Jun, 2022 4
10 Jun, 2022 4
10 Jun, 2022 4
10 Jun, 2022 4
10 Jun, 2022 4
10 Jun, 2022 4
16 May, 2022 SC 13G
13 May, 2022 10-Q
12 May, 2022 8-K
11 May, 2022 4
11 May, 2022 4
11 May, 2022 4
27 Apr, 2022 DEF 14A
27 Apr, 2022 DEFA14A
15 Apr, 2022 PRE 14A
16 Mar, 2022 CT ORDER
11 Mar, 2022 10-K
10 Mar, 2022 8-K
1 Mar, 2022 4
14 Feb, 2022 SC 13G/A
14 Feb, 2022 SC 13G/A
14 Feb, 2022 SC 13G/A
14 Feb, 2022 SC 13G/A
7 Feb, 2022 4
2 Feb, 2022 SC 13G/A
26 Jan, 2022 4
26 Jan, 2022 4
26 Jan, 2022 4
26 Jan, 2022 4
12 Jan, 2022 S-8
5 Jan, 2022 8-K
4 Jan, 2022 SC 13G/A
13 Dec, 2021 424B3
10 Dec, 2021 EFFECT
9 Dec, 2021 SC 13D/A
8 Dec, 2021 CORRESP
8 Dec, 2021 UPLOAD
6 Dec, 2021 D
2 Dec, 2021 S-1
1 Dec, 2021 4
30 Nov, 2021 8-K
29 Nov, 2021 S-8
24 Nov, 2021 8-K
12 Nov, 2021 10-Q
10 Nov, 2021 8-K
18 Oct, 2021 8-K
12 Oct, 2021 8-K
10 Aug, 2021 8-K
10 Aug, 2021 10-Q
10 Aug, 2021 424B5
16 Jun, 2021 8-K
15 Jun, 2021 4
15 Jun, 2021 4
15 Jun, 2021 4
15 Jun, 2021 4
15 Jun, 2021 4
15 Jun, 2021 4
15 Jun, 2021 4
15 Jun, 2021 4
15 Jun, 2021 4
27 May, 2021 DEFA14A
21 May, 2021 8-K
17 May, 2021 4
17 May, 2021 4
14 May, 2021 10-Q
13 May, 2021 8-K
3 May, 2021 8-K
30 Apr, 2021 DEF 14A
20 Apr, 2021 PRE 14A
16 Apr, 2021 4
16 Apr, 2021 4/A
17 Mar, 2021 EFFECT
16 Mar, 2021 4
16 Mar, 2021 4
16 Mar, 2021 4
16 Mar, 2021 4
16 Mar, 2021 4
16 Mar, 2021 4
16 Mar, 2021 4
16 Mar, 2021 4
16 Mar, 2021 4
16 Mar, 2021 4
15 Mar, 2021 CORRESP
12 Mar, 2021 UPLOAD
10 Mar, 2021 S-3
9 Mar, 2021 10-K
9 Mar, 2021 8-K
8 Mar, 2021 SC 13G
17 Feb, 2021 4
17 Feb, 2021 8-K
17 Feb, 2021 4
16 Feb, 2021 SC 13G/A
12 Feb, 2021 SC 13G/A
12 Feb, 2021 SC 13G/A
5 Feb, 2021 4
5 Feb, 2021 4
5 Feb, 2021 4
5 Feb, 2021 4
4 Feb, 2021 S-8
28 Jan, 2021 8-K
27 Jan, 2021 4
27 Jan, 2021 3
27 Jan, 2021 4/A
12 Jan, 2021 EFFECT
8 Jan, 2021 CORRESP
7 Jan, 2021 UPLOAD
Last update:2024-03-06 12:26:20.127207
Regulus Therapeutics Inc. by TradingView

Sign Up to Subscribe